Physician profile
Matthew R Endara
NPI 1033370937
$204,455.44
in general payments reported to CMS, 2019-2025
16 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $27K · 2021: $4,381 · 2022: $25K · 2023: $27K · 2024: $47K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $53K · Consulting Fee: $33K · Travel and Lodging: $14K · Food and Beverage: $4,073 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,454 · Education: $2,253 · Honoraria: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $53,475.00 |
| Consulting Fee | $32,750.00 |
| Travel and Lodging | $13,700.19 |
| Food and Beverage | $4,073.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,454.00 |
| Education | $2,252.96 |
| Honoraria | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $138,110.61 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $65,473.60 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $166.78 | 2023-2025 | |
| Motiva USA, LLC | $140.11 | 2024 | |
| Sientra, INC. | $133.97 | 2020-2022 | |
| Smith+Nephew, INC. | $107.11 | 2022-2024 | Grafix, Collagenase Santyl, Regranex |
| Allergan, INC. | $86.03 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $53.05 | 2022-2024 | |
| Mentor Worldwide LLC | $46.58 | 2022-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Reapplix INC. | $26.50 | 2025 | 3c Patch Kit - Box |
| Tela Bio, INC. | $24.14 | 2021 | |
| Access Pro Medical, LLC | $19.96 | 2025 | Matriderm |
| Acera Surgical, INC. | $18.09 | 2023 | Restrata Wound Matrix |
| Solventum Corporation | $17.76 | 2024 | V.A.C. Dermatac, Activ.A.C. |
| Kci USA, INC. | $16.25 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $14.90 | 2025 | Monocryl, Dermabond Prineo, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Endara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.